NCT01684254

Brief Summary

The present project will focus on evaluating the technical efficacy of the in-shoe gait monitoring device (ActiveGait) through laboratory based biomechanical gait assessments of children who exhibit gait deviations due to CP or idiopathic toe walking wearing the device.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

September 10, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2012

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

March 13, 2017

Status Verified

March 1, 2017

Enrollment Period

6.6 years

First QC Date

September 10, 2012

Last Update Submit

March 9, 2017

Conditions

Keywords

Cerebral PalsyHome monitoringGaitSensorized Shoe

Outcome Measures

Primary Outcomes (1)

  • Toe Walking Severity (TWS) index

    Measure for quantifying changes in severity of toe walking over time based on Center of Pressure trajectories computed by the sensorized insole

    1 day

Secondary Outcomes (1)

  • Edinburgh Visual Scale (EVS) score

    1 day

Study Arms (1)

Children with Cerebral Palsy (CP)

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children diagnosed with CP

You may qualify if:

  • able to ambulate 50 feet on level ground without the assistance of a person
  • able to ambulate on ramps and stairs without the assistance of a person
  • demonstrate a toe-walking pattern at the time of enrollment
  • medically stable
  • able to understand directions and follow simple instructions

You may not qualify if:

  • any cardiopulmonary, orthopedic, and neurological conditions other than CP that would prevent them from performing the motor tasks of interest

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spaulding Rehabilitation Hospital

Boston, Massachusetts, 02129, United States

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Motion Analysis Laboratory

Study Record Dates

First Submitted

September 10, 2012

First Posted

September 12, 2012

Study Start

May 1, 2010

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

March 13, 2017

Record last verified: 2017-03

Locations